Quarterly report pursuant to Section 13 or 15(d)

Segment reporting (Details) - Schedule of financial information represents the operating results of the reportable segments

v3.21.1
Segment reporting (Details) - Schedule of financial information represents the operating results of the reportable segments - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Apr. 30, 2021
Apr. 30, 2020
Apr. 30, 2021
Apr. 30, 2020
Clinical Services [Member]        
Segment Reporting Information [Line Items]        
Revenues – Services and Products $ 25,018 $ 9,739 $ 70,229 $ 35,032
Grant income   747   747
Cost of revenues 12,733 9,133 37,436 30,351
Total   10,486   35,779
Capital expenditures 1,544 225 2,425 514
Research and development 173 395 454 1,118
Selling, general and administrative 7,029 5,902 19,552 18,012
Legal and related expenses 95 52 191 140
Total operating costs and expenses 20,030 15,482 57,633 49,621
Operating income (loss) 4,988 (4,996) 12,596 (13,842)
Interest (4) (7) (14) (29)
Other 1 1 30 20
Foreign exchange loss  
Net income (loss) 4,985 (5,002) 12,612 (13,851)
Depreciation and amortization included above 399 373 1,189 1,174
Products [Member]        
Segment Reporting Information [Line Items]        
Revenues – Services and Products 7,779 6,417 22,689 20,715
Cost of revenues 4,018 3,345 11,718 10,223
Total   6,417   20,715
Capital expenditures 180 60 378 205
Research and development 643 580 1,868 1,599
Selling, general and administrative 2,810 2,667 7,848 7,954
Legal and related expenses 10   16 1
Total operating costs and expenses 7,481 6,592 21,450 19,777
Operating income (loss) 298 (175) 1,239 938
Interest 11 11 29 45
Other 2 4 6 (1)
Foreign exchange loss (33) (358) 428 (88)
Net income (loss) 278 (518) 1,702 894
Depreciation and amortization included above 208 278 581 781
Therapeutics [Member]        
Segment Reporting Information [Line Items]        
Revenues – Services and Products
Cost of revenues  
Capital expenditures      
Research and development 20 188 66 565
Selling, general and administrative 17 50  
Legal and related expenses
Total operating costs and expenses 37 188 116 565
Operating income (loss) (37) (188) (116) (565)
Interest    
Other    
Foreign exchange loss  
Net income (loss) (37) (188) (116) (565)
Depreciation and amortization included above    
Other [Member]        
Segment Reporting Information [Line Items]        
Revenues – Services and Products
Cost of revenues  
Capital expenditures 23 67  
Research and development  
Selling, general and administrative 2,226 2,492 5,659 6,927
Legal and related expenses 956 1,873 3,786 5,540
Total operating costs and expenses 3,182 4,365 9,445 12,467
Operating income (loss) (3,182) (4,365) (9,445) (12,467)
Interest 53 83 (55) 479
Other (91) 130 (91) 315
Foreign exchange loss  
Net income (loss) (3,220) (4,152) (9,591) (11,673)
Depreciation and amortization included above 66 66 198 196
Consolidated [Member]        
Segment Reporting Information [Line Items]        
Revenues – Services and Products 32,797 16,156 92,918 55,747
Grant income   747   747
Cost of revenues 16,751 12,478 49,154 40,574
Total   16,903   56,494
Capital expenditures 1,747 285 2,870 719
Research and development 836 1,163 2,388 3,282
Selling, general and administrative 12,082 11,061 33,109 32,893
Legal and related expenses 1,061 1,925 3,993 5,681
Total operating costs and expenses 30,730 26,627 88,644 82,430
Operating income (loss) 2,067 (9,724) 4,274 (25,936)
Interest 60 87 (40) 495
Other (88) 135 (55) 334
Foreign exchange loss (33) (358) 428 (88)
Net income (loss) 2,006 (9,860) 4,607 (25,195)
Depreciation and amortization included above 673 717 1,968 2,151
Selling, General and Administrative Expenses [Member] | Clinical Services [Member]        
Segment Reporting Information [Line Items]        
Selling, general and administrative 9 21 28 88
Selling, General and Administrative Expenses [Member] | Products [Member]        
Segment Reporting Information [Line Items]        
Selling, general and administrative 41 14 73 58
Selling, General and Administrative Expenses [Member] | Therapeutics [Member]        
Segment Reporting Information [Line Items]        
Selling, general and administrative  
Selling, General and Administrative Expenses [Member] | Other [Member]        
Segment Reporting Information [Line Items]        
Selling, general and administrative 208 172 473 582
Selling, General and Administrative Expenses [Member] | Consolidated [Member]        
Segment Reporting Information [Line Items]        
Selling, general and administrative 258 207 574 728
Cost of Revenues [Member] | Clinical Services [Member]        
Segment Reporting Information [Line Items]        
Cost of revenues 39   66  
Cost of Revenues [Member] | Products [Member]        
Segment Reporting Information [Line Items]        
Cost of revenues      
Cost of Revenues [Member] | Therapeutics [Member]        
Segment Reporting Information [Line Items]        
Cost of revenues      
Cost of Revenues [Member] | Other [Member]        
Segment Reporting Information [Line Items]        
Cost of revenues      
Cost of Revenues [Member] | Consolidated [Member]        
Segment Reporting Information [Line Items]        
Cost of revenues 39   66  
Total [Member] | Clinical Services [Member]        
Segment Reporting Information [Line Items]        
Total 48 21 94 88
Total [Member] | Products [Member]        
Segment Reporting Information [Line Items]        
Total 41 14 73 58
Total [Member] | Therapeutics [Member]        
Segment Reporting Information [Line Items]        
Total    
Total [Member] | Other [Member]        
Segment Reporting Information [Line Items]        
Total 208 172 473 582
Total [Member] | Consolidated [Member]        
Segment Reporting Information [Line Items]        
Total $ 297 $ 207 $ 640 $ 728